Delayed Nyse  -  05/27 04:00:01 pm EDT
0.7681 USD   +5.45%
05/10TRANSCRIPT : Regis Corporation, Q3 2022 Earnings Call, May 10, 2022
05/10REGIS CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
05/10REGIS : Fiscal Q3 Earnings Snapshot
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news


12/23/2021 | 06:37am EDT

Matt Doctor Named Interim CEO

MINNEAPOLIS, December 23, 2021 -- Regis Corporation (NYSE: RGS), a leader in the haircare industry, whose primary business is franchising technology-enabled hair salons, today announced that Felipe Athayde, President and Chief Executive Officer, has resigned from the Company. In connection with his resignation, the Board of Directors appointed Matthew Doctor, the Company's Executive Vice President and Chief Strategy Officer, as Interim Chief Executive Officer effective December 23, 2021. Mr. Athayde will remain an employee and a member of the Company's Board of Directors through March 19, 2022. The Board of Directors is commencing a search for a successor President and Chief Executive Officer, which will include consideration of internal and external candidates.
Mr. Doctor joined the Company in February 2021, after serving as a consultant to the Company since December 2020. Mr. Doctor brings relevant experience across all aspects of Regis' business, having been a franchisee of other brands, held numerous roles at a global franchisor, and worked in finance as an investment banker. Prior to joining Regis, Mr. Doctor was Chief Financial Officer of Kava Restaurants LLC, a Tim Horton's franchisee that grew to 83 restaurants. Prior to Kava, he held positions of increasing responsibility both domestically and internationally at Restaurant Brands International, including Head of Global Development and Franchisee Performance for the Burger King brand.Before joining Restaurant Brands International, Mr. Doctor worked as an investment banker in the Financial Institutions Group at J.P. Morgan.
During his tenure at Regis, Mr. Doctor accelerated the transition of corporate to franchise salons and was instrumental in driving additional G&A savings, both of which have had a significant impact on the profitability of the Company.
The Board also appointed Jim Lain, the Company's President of Franchise Operations, to the position of Chief Operating Officer, and Michael Ferranti, the Company's Senior Vice President of People & Culture to the position of Executive Vice President and Chief People Officer.
"The Board is grateful for Felipe's leadership and the franchise expertise he brought to our transformed business model," said David Grissen, Regis' Chair of the Board of Directors. "Felipe assembled and developed a stellar team - Matt included - with complementary skill sets across operations, development, technology, recruiting and finance that position us well to continue leveraging our platform following his departure."

"The Board is pleased to appoint Matt as Interim Chief Executive Officer," continued Mr. Grissen. "Since he joined Regis, Matt has already made significant contributions to our business, and, together with the rest of the leadership team, is well positioned to continue seamless execution of our priorities. Matt has the full backing of the Board during this time and we look forward to his continued contributions."
"I am humbled and grateful to be leading Regis during what continues to be a dynamic business environment," said Mr. Doctor. "I could not be more excited to be driving our business forward with our franchise partners and a leadership team that I have so much respect for, both as colleagues and as people. There is a lot to be done, both in our core business and in exploring opportunities while navigating this ever-changing environment. It is key for us to continue to foster our well-known brands while also recognizing the need to be flexible and pivot where warranted. We are well positioned to unleash the potential of our scaled platform and proprietary technology solution."
About Regis Corporation
Regis Corporation (NYSE:RGS) is a leader in the beauty salon industry. As of September 30, 2021, the Company franchised, owned or held ownership interests in 5,843 locations worldwide. Regis' locations operate under concepts such as Supercuts®, SmartStyle®, Cost Cutters®, Roosters® and First Choice Haircutters®. Regis maintains an ownership interest in Empire Education Group in the U.S.

Kersten Zupfer


Regis Corporation published this content on 23 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 December 2021 11:36:00 UTC.

© Publicnow 2021
05/10TRANSCRIPT : Regis Corporation, Q3 2022 Earnings Call, May 10, 2022
05/10REGIS CORP Management's Discussion and Analysis of Financial Condition and Results of ..
05/10REGIS : Fiscal Q3 Earnings Snapshot
05/10Earnings Flash (RGS) REGIS CORPORATION Reports Q3 Loss $-0.09
05/10Earnings Flash (RGS) REGIS CORPORATION Posts Q3 Revenue $64.7M
05/10Regis Corporation Reports Third Quarter 2022 Results
05/05Regis Promotes Matthew Doctor to President, CEO
05/05REGIS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits ..
05/05Regis Corporation Appoints Matthew Doctor as President and Chief Executive Officer
05/05Regis Corporation Appoints Matthew Doctor as President and Member of Board of Directors
More news
Analyst Recommendations on REGIS CORPORATION
More recommendations
Financials (USD)
Sales 2021 415 M - -
Net income 2021 -113 M - -
Net Debt 2021 803 M - -
P/E ratio 2021 -2,97x
Yield 2021 -
Capitalization 35,0 M 35,0 M -
EV / Sales 2020 1,79x
EV / Sales 2021 2,74x
Nbr of Employees 735
Free-Float 85,9%
Duration : Period :
Regis Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REGIS CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus -
Number of Analysts 0
Last Close Price 0,77
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Matthew Doctor President, Chief Executive Officer & Director
Kersten D. Zupfer Chief Accounting Officer, VP & Controller
David J. Grissen Chairman
John Davi Chief Technology Officer & Executive VP
Jim Brian Lain Chief Operating Officer
Sector and Competitors